Join our team

Why work at BRI?

Benaroya Research Institute (BRI) is a world leader in human immunology. We have a bold mission: To predict, prevent, reverse and cure immune system diseases. We’re currently hiring new team members who are passionate about changing the course of immune system diseases.

At BRI, we study everything from autoimmune disease to cancer to COVID-19. And we examine the immune system as a whole — in healthy people and in people with disease — aiming to understand how these disorders start and how to rebalance the immune system back to health.

Equipped with innovative tools and robust biorepositories, our team spends every day tackling some of immunology’s biggest mysteries and working toward our vision: A healthy immune system for everyone.

See all open positions

Each department contributes to our work in a meaningful way.  We can't wait to have you join us and contribute your unique talents and perspective.  
Full-Width - Scientific Human Fibroblasts in a co-culture system

Postdoctoral Opportunities at BRI

A postdoctoral research associate position at BRI offers the opportunity to work with world leading immunologists, experts in bioinformatics, flow cytometry and cell imaging to name a few.  Collaborative.  Agile.  Experts.  Just a few things we don't mind being called.   
Learn about our program
“When I was looking for the next step in my career, my goal was to be closer to patients and clinical research. I had heard of BRI and thought a postdoc here would be a great way to do that. I’ve already learned so much and seen how translational the work is. I’m looking forward to being involved with so many projects where everyone is working together with one goal.”   
Christine Bender, PhD, Long Laboratory Postdoctoral Researcher

Use the latest tools and resources

BRI is equipped with leading-edge tools, technologies and centers. If a tool doesn’t exist, we’ll make it. We’re home to:
Research Project Preview - Freezer Sample Extract

9 Robust Biorespositories

for healthy controls and across diseases including multiple sclerosis, type 1 diabetes and inflammatory bowel disease.
Learn about our samples
Research Project Preview - Researchers Bays

4 Core Labs

including tetramer core, cell and tissue analysis and human immunophenotyping — led by experts in each field.
Visit our central resources
Research Project Preview - Scientific Pink Shades

Centers of Discovery

carrying research from the lab to the clinic and using the advanced tools to push science forward.
How we collaborate with each other

Join a Collaborative Culture

At BRI, collaboration drives and inspires us. We built our organization to bring together experts from across science and technology. We believe in this approach because we know what happens when individuals with unique backgrounds and expertise team up: We build new tools. We ask different questions. And we make discoveries that change lives.

Our team of about 300 – which includes some of the world’s foremost immunologists – collaborates:

  • Across fundamental, translational and clinical research, using the latest lab discoveries to inform new treatments and therapies.
  • With clinicians at Virginia Mason Franciscan Health to run clinical trials, collect patient samples and use clinical insights to pose and answer research questions.
  • Between lab scientists and data scientists.
  • With scientists from across the globe and other Seattle institutions – including the University of Washington, Fred Hutchinson Cancer Center, Allen Institute and Seattle Children’s Research Institute.
Bio CRC Consult Best Dad

Feature Position at BRI: Clinical Research Project Coordinator

The Clinical Research Project Coordinator coordinates projects and processes and provides administrative support within the Clinical Research Program (CRP) at the Benaroya Research Institute.  Working with clinicians at the Virginia Mason Seattle Medical Center, the Clinical Research Program differentiates itself by focusing on patient-centered research.
Join the Clinical Research Program Team

Live and work in an enriching environment

When you join BRI, you become part of a team built on inquiry, collaboration, innovation and respect. We love living in the Seattle-area and working at BRI because:

  • Our city is a hub for immunology and life sciences. Seattle is a nexus for immunology and immune-therapy companies. You’ll join a thriving community of scientists working toward the next generation of discoveries, treatments and cures.
  • Temperate winters, beautiful summers. Seattle has something for everyone — food, arts, music, culture, family activities. A nature-lover’s paradise, our city is surrounded by water and mountains and is an exceptional place to get outside during every season.
  • Flexible options for some positions. While some roles require standard hours in the lab or office, we offer remote work and flexible hours when possible.
Full-width - Downtown Seattle Skyline Sky


BRI offers a competitive benefits package to eligible employees. Learn more about benefits at BRI.

  • Medical, dental, vision hardware insurance
  • Flexible spending accounts: health care, dependent care, commuter
  • Short and long-term disability and life and AD&D insurance
  • 403(b) retirement plan with matching funds after one year of employment
  • PTO: 13 holidays, three weeks of vacation and two weeks of sick leave per year
  • Employee assistance program
  • Tuition reimbursement program
  • Subsidized bus pass
  • YMCA rebate and other fitness club discounts
  • Voluntary benefits, e.g., pet insurance, accident, critical illness, identify theft


BRI endeavors to make accessible to any and all users. If you would like to contact us regarding the accessibility of our website or need assistance completing the application process, please contact Human Resources at 206-287-5646 or email

Affirmative Action Plan & Equal Employment Opportunity

Benaroya Research Institute is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, citizenship, disability or protected veteran status.

Please review BRI's AAP and EEO Policy Statement. If you'd like more information on your EEO rights under the law, please see EEO is the Law. Please review BRI's Compensation Transparency Nondiscrimination Provision.

Careers Interns Group 2019
BRI Intern Class

Educational Opportunities at BRI

Benaroya Research Institute is committed to educating and mentoring the next generation and encouraging young people to enter the field of science. BRI provides undergraduate internships, mentors graduate students and engages postdoctoral trainees from all over the world.
Learn more about our educational opportunities


News icon

COVID-19 mRNA Vaccination Does Not Promote Autoantibody Development

Read More

New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells

Learn more ➡
News icon

New Study Finds That Germinal Centers Are Regulated by Thymic Stromal Lymphopoietin Signaling in B Cells and T Cells

Read More

Blog Stories

Blog Main Image - 3D Biological Cells Blue
March 29, 2023

Learning How Tregs Keep Your Immune System in Check

The immune system keeps us healthy by maintaining a delicate balance. Every cell has a purpose: Some sound the alarm when they see an invader. Some attack germs that don’t belong. And some patrol the other cells in the immune system to make sure they’re doing their job.
Read Article
Blog Main Image - Clinician Woman Talking Patient Man Senior 2
March 14, 2023

Prediction and Prevention: A New Paradigm in Autoimmune Disease

The FDA recently approved teplizumab, a groundbreaking therapy that signals a paradigm shift in treating not only T1D but all autoimmune diseases.
Read Article
Blog Main Image - Paper DNA Profile People
March 14, 2023

Computer Science Reveals Possible Drug Target for Deadly Childhood Leukemia

Dr. Bolouri is an expert in using computer science to advance biomedical research. Working with Soheil Meshinchi, MD, PhD, and his team at Fred Hutch Cancer Center, they made a recent discovery that may lead to new treatments for certain forms of pediatric acute myeloid leukemia (AML).
Read Article

Immuno-what? Hear the latest from BRI

Keep up to date on our latest research, new clinical trials and exciting publications.